Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Has announcements
×
Metastatic Hormone Sensitive Prostate Cancer
×
Clear all
Filters
3
NCT02677896
2025-10-24
ARCHES
Astellas Pharma Inc
Phase 3
Completed
1,150 enrolled
23 charts
1 FDA